|Application:||Gene expression microarray analysis|
|Number of samples:||48|
|Release date:||Jun 13 2008|
|Last update date:||Aug 28 2018|
|Diseases:||Blast Injuries, Leukemia, Myelogenous, Chronic, BCR-ABL Positive|
|Dataset link||Transcriptional repression of c-Myb and GATA-2 is involved in the effects of C/EBPα in p210 BCR/ABL-expressing cells|
48 samples total. 4-HT-treated 32D-BCR/ABL cells transduced with the MigRI empty vector, MigRI WT C/EBPα-ER , MigRI K298E C/EBPα-ER (a DNA binding-deficient mutant) or MigRI-delta(177-191) C/EBPα-ER (a mutant deficient in CDK2/CDK4 interaction). Total RNA was extracted at 0, 6, 9 and 12h post-4-HT treatment in triplicate and hybridized onto the Affymetrix MOE430 _2 array.